All In Biotech

Free tool

FAERS Monitor: Codeine Sulfate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202245 or its brand name (Codeine Sulfate, Codeine Sulfate). Reports on generic versions are filed under their own applications.

Reports

3,309

Serious

2,121

64% of reports

Hospitalization

668

Death reported

799

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug hypersensitivity817
  • nausea506
  • drug ineffective400
  • malaise380
  • vomiting373
  • headache371
  • arthralgia363
  • diarrhoea352
  • dyspnoea338
  • fatigue310
  • cough309
  • pain286
  • pruritus273
  • abdominal pain upper271
  • off label use267

Reports by year received

View as table
YearReports
20048
20051
20071
200921
2010233
2011387
2012501
2013154
2014232
2015102
2016122
2017144
2018156
2019243
2020154
2021120
2022200
2023140
2024201
2025131
202658

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,850 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug hypersensitivitySignal81726.925.420,486
abdominal pain upperSignal2718.47.51,768
coughSignal3097.06.31,606
arthralgiaSignal3635.65.01,377
malaiseSignal3805.55.01,427
vomitingSignal3735.04.61,233
pruritusSignal2734.54.0758
nauseaSignal5064.13.81,211
dyspnoeaSignal3383.83.4712
headacheSignal3713.83.4772
diarrhoeaSignal3523.53.1635
painSignal2863.02.6380
fatigueSignal3102.52.3297
off label use2671.91.7126
drug ineffective4001.91.8190

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.